AKUMS DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,118 Cr | ₹4,178 Cr | ₹3,655 Cr | ₹3,672 Cr | ₹2,723 Cr |
What is the latest Revenue of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹4,118 Cr |
| Mar2025 | ₹4,178 Cr |
| Mar2024 | ₹3,655 Cr |
| Mar2023 | ₹3,672 Cr |
| Mar2022 | ₹2,723 Cr |
How is Revenue of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,118 Cr | -1.44 | |
| Mar2025 | ₹4,178 Cr | 14.32 | |
| Mar2024 | ₹3,655 Cr | -0.46 | |
| Mar2023 | ₹3,672 Cr | 34.87 | |
| Mar2022 | ₹2,723 Cr | - | |
Compare Revenue of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹11,306.8 Cr | 3.7% | -12.2% | 46.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 3.7% |
-12.2% |
46.8% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses